I have a couple of comments.
First of all, we do need a level presence policy in place. Mr. Van Acker alluded to zero not being realistic, and it is crystal clear that's not realistic along the supply value chain.
The one thing I would like to make mention of, which Mr. Van Acker also alluded to, is China. There are one billion people in China. China is investing 1% of its GDP in R and D specifically around biotechnology around the world. We in Canada and even North America are leaders in the regulatory and scientific approval process and in bringing forth biotech trades. We've been in the industry for 20 years, commercially for the last 15 years, and we need to take a leadership role in developing those policies.
At least from my viewpoint, a lot of the countries from around the world look to Canada as a leader in developing policies and procedures. With China coming on board, we really need to have something in place to have a nice dialogue with them. As Mr. Van Acker said, what are we going to say when these AP or LLP come into place when exports from China come to Canada? We need to have a solution and be ready, not be reactive.
That's my comment on that.